HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications.
Tarantino P, Niman SM, Erick TK, Priedigkeit N, Harrison BT, Giordano A, Nakhlis F, Bellon JR, Parker T, Strauss S, Jin Q, King TA, Overmoyer BA, Curigliano G, Regan MM, Tolaney SM, Lynce F.
Tarantino P, et al. Among authors: bellon jr.
Eur J Cancer. 2022 Oct;174:277-286. doi: 10.1016/j.ejca.2022.07.001.
Eur J Cancer. 2022.
PMID: 36116830